Memopezil Reviews: Buyer Warning — Only Direct Orders Carry the Guarantee, Company Says

Memopezil Reviews evaluate a fully disclosed five-ingredient label as marketplace listings advertise vitamins the panel does not contain

By the Health & Science Desk | NEW YORK, NY — Aug. 18, 2026 — Memopezil today issued a consumer notice on third-party marketplace listings using its name, confirming that it distributes only through realmemopezil.com. Product purchased elsewhere is not covered by the company’s money-back guarantee.

Memopezil is a five-ingredient capsule supplement combining botanical extracts and amino acids, taken at two capsules daily. The company’s money-back guarantee runs 60 days from purchase, with refunds available between day 30 and day 60.

The notice sets out a set of checks buyers can perform from a listing page alone, without contacting the company. The two most decisive concern the formula and the number of days a package is said to last.

Memopezil Official Product Page — realmemopezil.com (affiliate link — see disclosure below)

Memopezil Product Overview

Memopezil is a capsule dietary supplement intended for adult use. The manufacturer’s recommended serving is two capsules daily, taken in the morning with a glass of water, approximately 20 to 30 minutes before a meal. The product label states 60 capsules per bottle. At the recommended two-capsule serving, one bottle is therefore a 30-day supply, which is the basis on which the company sells its two-, three- and six-bottle packages as 60-, 90- and 180-day supplies respectively.

The Supplement Facts panel declares 30 servings per container and five active ingredients, each with an individually disclosed amount. There is no proprietary blend. Per two-capsule serving:

• Branched Chain Amino Acids 2:1:1 (L-Leucine, L-Isoleucine, L-Valine) — 540 mg

• Bacopa Monnieri Extract — 200 mg

• Rhodiola Rosea Extract (3% salidroside) — 100 mg

• L-Theanine — 100 mg

• Panax Ginseng Extract — 90 mg

Total declared actives are 1,030 mg per serving. No Daily Value is established for any of the five, and each is marked accordingly on the panel. Branched chain amino acids account for slightly more than half the declared weight, making them the largest single component of the formula. Other ingredients are microcrystalline cellulose, hydroxypropyl methylcellulose (capsule) and magnesium stearate. The panel carries no major food allergen declaration.

The label states the product is made in the USA with globally sourced ingredients and manufactured in an FDA-registered facility. The company states the formulation contains no stimulants and no caffeine, and neither appears on the panel.

The bottle front panel carries the structure and function statements “supports a sharper mind and healthy memory,” “promotes focus and concentration” and “supports cognitive function and mental clarity,” each accompanied by the disclaimer required for dietary supplements under federal labeling rules, together with the declaration “60 Capsules” and “Dietary Supplement.”

The formula contains no vitamins and no minerals — this is the single most useful verification point available to a buyer. Vitamins A, B, C, D and E do not appear on the Supplement Facts panel, and neither do added minerals. The panel lists five actives — four botanical or amino-acid entries plus a branched chain amino acid complex — and nothing else. A listing that describes Memopezil as a multivitamin, or that advertises vitamins and minerals among its contents, is not describing the product the company sells.

Statement From Memopezil

“Our panel lists five ingredients with the milligram amount printed next to each one. There are no vitamins in it and no added minerals in it,” said Kevin S., product head at Memopezil. “When a listing sells something called Memopezil and advertises vitamins A through E and a mineral blend, that is not a version of our product — it is a different product using our name. A buyer cannot tell that from a photograph, so we are publishing the panel, the bottle count and the serving size, and asking people to compare before they buy.”

Memopezil Authorized Distribution and Third-Party Marketplace Listings

Memopezil is sold through the company’s own website at realmemopezil.com. The company states that it does not supply general third-party marketplace platforms and has no commercial relationship with sellers offering Memopezil on those platforms.

The guarantee does not transfer — the 60-day money-back guarantee, under which refunds are available between day 30 and day 60 following a minimum 30-day trial period, applies to purchases processed through the company’s own checkout. A marketplace purchase is a transaction with that seller. The company has no record of it, no ability to verify it, and no obligation under its own return policy. The bonus materials offered with three- and six-bottle orders through the company’s checkout are likewise not supplied with marketplace purchases.

Product condition cannot be verified — for product that did not move through the company’s own supply chain, Memopezil cannot confirm storage conditions, handling, remaining shelf life, or whether the contents correspond to the label.

Contents cannot be confirmed — the company can verify the composition of product produced to its specification and shipped through its own channel. It cannot verify the composition of product sold by parties it does not supply.

Separately, and without reference to any listing of this product, the U.S. Food and Drug Administration maintains a public notification list of dietary supplements found to contain undeclared pharmaceutical ingredients, and advises consumers that such products can interact with prescription medications.

How to check a listing — the identifiers below are taken from the Supplement Facts and front panels printed on bottles in current production. The printed label is the controlling statement of composition. Marketing summaries, ingredient highlights and promotional copy on any web page, including the company’s own, are abbreviated descriptions and do not supersede the printed panel; where the two differ, the panel governs. The company publishes the following identifiers so buyers can compare a listing against the printed label:

• Formula: five declared actives — branched chain amino acids 540 mg, Bacopa monnieri 200 mg, Rhodiola rosea 100 mg, L-theanine 100 mg and Panax ginseng 90 mg. No vitamins. No added minerals. A listing advertising vitamins A, B, C, D or E, a mineral blend, or “multivitamin” support is not describing the company’s formula.

• Panel format: every amount is individually disclosed. There is no proprietary blend on this label. A panel showing a blend total rather than per-ingredient milligrams is not the company’s panel.

• Servings per container: 30, printed on the panel.

• Bottle count: 60 capsules per bottle, declared on the front panel.

• Serving: two capsules daily. Any package’s duration follows from that figure. A 60-capsule bottle is a 30-day supply at the recommended serving, not a two-month or three-month supply.

• Package duration: one bottle is a 30-day supply at the recommended serving, and the company sells its two-, three- and six-bottle packages as 60-, 90- and 180-day supplies. Listings that describe an identical capsule count as lasting one month, two months and three months cannot all be consistent with a fixed daily serving.

• Brand rendering: the product name is a single word, Memopezil. Listings rendering it as two words are not using the company’s brand presentation.

• Channel: the company’s own checkout at realmemopezil.com. The word “official” appearing in a marketplace listing title is seller-supplied text and does not indicate authorization by the company.

Buyers who cannot match a seller to the company’s own channel, or who receive a package whose panel differs from the formula above, may contact support at support@realmemopezil.com. Consumers who purchased through a marketplace listing and wish to raise a concern should do so through that platform’s buyer-protection process, as the transaction was not made with Memopezil.

Independent reporting channels — consumers who believe a marketplace listing misrepresents a product may file a report with the U.S. Federal Trade Commission at reportfraud.ftc.gov. Adverse events associated with any dietary supplement may be reported to the U.S. Food and Drug Administration through the MedWatch program at fda.gov/medwatch or by telephone at 1-800-FDA-1088. Both are independent public channels administered by federal agencies and are not operated by, or reported to, Memopezil.

Memopezil Ingredient Overview

All citations below describe research conducted under conditions unaffiliated with Memopezil. Because this label discloses every amount individually, the doses supplied can be compared directly against the doses used in the published literature, and that comparison is set out for each ingredient. Several cited studies used dosages or preparations that differ substantially from those supplied here. These citations establish that each ingredient has been studied. They do not constitute clinical evidence that Memopezil produces equivalent outcomes, and no such equivalence is claimed.

Branched Chain Amino Acids (540 mg). The largest declared component, supplying L-leucine, L-isoleucine and L-valine in a 2:1:1 ratio. The published human literature on branched chain amino acids concerns exercise performance and muscle protein synthesis, at daily intakes in the gram range — roughly ten to forty times the amount supplied here. Work on branched chain amino acids and brain function (Fernstrom, J.D., 2005, Journal of Nutrition) concerns their competition with other large neutral amino acids for transport across the blood-brain barrier rather than a cognitive benefit. No controlled human trial has established a cognitive indication for branched chain amino acids at this dose in healthy adults.

Bacopa Monnieri (200 mg). A creeping herb with documented traditional use in Ayurvedic practice. A meta-analysis of randomized controlled trials published in the Journal of Ethnopharmacology (Kongkeaw, C., Dilokthornsakul, P., Thanarangsarit, P., Limpeanchob, N., & Norman Scholfield, C., 2014, doi:10.1016/j.jep.2013.11.008) examined standardized Bacopa monnieri extract across randomized trials in adult subjects. Trials in that literature commonly used 300 mg daily of a standardized extract over 12 weeks — half again the 200 mg supplied here. The review reported improvement on some measures of information processing speed and reaction time, and did not find consistent effects across all cognitive domains assessed.

Rhodiola Rosea (100 mg, 3% salidroside). A flowering plant of cold high-altitude regions with documented traditional use in Scandinavian and Russian herbal practice. A systematic review of randomized clinical trials published in Phytomedicine (Hung, S.K., Perry, R., & Ernst, E., 2011) assessed the evidence base and concluded that the available trials were limited in number and methodological quality, and that the evidence was not sufficient to establish efficacy. Trials in that literature used daily doses in the range of roughly 100 to 600 mg of standardized root extract. The amount supplied here sits at the bottom of that range.

L-Theanine (100 mg). An amino acid found naturally in tea leaves. A randomized controlled trial published in Nutrients (Hidese, S., Ogawa, S., Ota, M., et al., 2019, 11(10), 2362, doi:10.3390/nu11102362) administered 200 mg of L-theanine daily to adult subjects over four weeks — twice the amount supplied here — and assessed stress-related symptoms and cognitive function. The trial reported improvement on some sleep and executive-function measures, in a single study of modest size.

Panax Ginseng (90 mg). A root used in East Asian herbal practice. A Cochrane systematic review (Geng, J., Dong, J., Ni, H., et al., 2010, Cochrane Database of Systematic Reviews, doi:10.1002/14651858.CD007769.pub2) examined ginseng for cognition and concluded that there was no convincing evidence of a cognitive benefit in healthy participants. This is the most rigorous review of this ingredient for this endpoint, and it is a negative finding. Trials in that literature used daily doses in the range of roughly 200 to 900 mg, so the 90 mg supplied here falls below the doses tested.

Read together, the panel supplies each of the four ingredients with cognitive-endpoint trial data at or below the doses used in the research cited above, and supplies its largest component at a small fraction of any dose studied for any endpoint. No published clinical trial has evaluated the complete Memopezil formulation as a finished product.

Memopezil Availability and Pricing

The company’s published pricing consists of the following multi-bottle packages. The per-bottle figures apply only within each package:

• Two-bottle package: $158 total ($79 per bottle; 60-day supply; two bottles of 60 capsules), plus shipping

• Three-bottle package: $207 total ($69 per bottle; 90-day supply), with complimentary U.S. shipping and bonus materials

• Six-bottle package: $294 total ($49 per bottle; 180-day supply), with complimentary U.S. shipping and bonus materials

Bonus materials offered with three- and six-bottle orders are digital titles: The Super Gut Code, 101 Herbal Cures, Sleep Live Better, the 10-Day Active Mind Challenge and a personalized usage guide. Every purchase placed through the company’s own checkout is covered by a 60-day money-back guarantee measured from the date of purchase, under which refund eligibility follows a minimum trial period of 30 days of use, opening the active refund window between day 30 and day 60. Buyers should confirm current terms, eligibility conditions and return instructions on the order page at the time of purchase and retain written confirmation, as commercial terms are controlled by the seller and may change.

Memopezil Official Product Page — realmemopezil.com (affiliate link — see disclosure below)

Memopezil Quality and Manufacturing

The label states that Memopezil is made in the USA with globally sourced ingredients and that the product has been manufactured in an FDA-registered facility. The Supplement Facts panel discloses the amount of every active ingredient individually rather than as a proprietary blend, which is the more transparent of the two formats permitted under 21 CFR 101.36. Non-active excipients are microcrystalline cellulose, hydroxypropyl methylcellulose forming the capsule shell, and magnesium stearate.

Manufacture in a facility registered with the U.S. Food and Drug Administration denotes compliance with federal facility registration requirements. It does not indicate that the Food and Drug Administration has evaluated or approved the finished dietary supplement, or verified any claim made about it.

Memopezil Usage Guidance and Safety Information

The label directs users to take two capsules daily with an 8-ounce glass of water, and for best results 20 to 30 minutes before a meal, or as directed by a healthcare professional. It instructs users not to exceed the recommended dose, and states that pregnant or nursing mothers, children under the age of 18, and individuals with a known medical condition should consult a physician before using this or any dietary supplement. It further directs that the product be kept out of the reach of children, not used if the safety seal is damaged or missing, and stored in a cool, dry place away from heat, light and humidity.

Prescription medication considerations — several components of this formula warrant discussion with a physician or pharmacist for adults taking prescription medication. Panax ginseng has documented potential to interact with anticoagulant medication, including warfarin, and with medications affecting blood glucose. Rhodiola rosea has documented potential to affect enzyme pathways involved in drug metabolism. Bacopa monnieri has documented cholinergic activity and published guidance advises caution alongside cholinergic and thyroid medications. Adults taking any prescription product should speak with a healthcare professional before use.

Format considerations — the product is supplied in capsule form at two capsules daily, in a hydroxypropyl methylcellulose shell. Buyers who have difficulty swallowing capsules should take this into account, as the company does not offer an alternative format.

Individual responses may vary — the company advises that consistent daily use alongside established eating, sleep and activity patterns is appropriate for evaluating the product’s contribution to a broader wellness routine, and that no supplement substitutes for those patterns.

For independent cognitive and brain-health information, readers are encouraged to consult the National Institute on Aging at nia.nih.gov, the National Center for Complementary and Integrative Health at nccih.nih.gov, or a licensed healthcare provider. These organizations are unaffiliated with Memopezil and receive no compensation in connection with this release.

Scope of This Announcement

This press release serves as a consumer notice regarding distribution channels and as a commercial availability and product specification summary. It is not a clinical trial reporting document, an independent review, or a laboratory analysis. No product testing was conducted for this release and no units were independently assayed.

No published clinical trial has evaluated the complete, finished Memopezil formulation. The scientific literature cited herein relates exclusively to individual ingredients tested under independent conditions, at doses that in several cases exceed those supplied by this product. Evidence strength varies markedly across the five ingredients: Bacopa monnieri and L-theanine have supportive human trial data but are supplied here below the doses used in those trials, the most rigorous review of Panax ginseng for cognition reports no convincing evidence, the Rhodiola rosea evidence base is assessed as insufficient, and the branched chain amino acid complex that makes up the largest share of the formula has no established cognitive indication at this dose.

Statements in this release concerning distribution, guarantee coverage and product composition are the company’s own. No allegation is made in this release regarding the identity, conduct or product authenticity of any individual third-party seller. Descriptions of marketplace listings refer to publicly visible listing text and not to the contents of any package.

Disclaimers

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Memopezil is a dietary supplement and is not a substitute for medical advice, diagnosis or treatment for any condition, and it is not a treatment for any form of cognitive decline. Consult a qualified healthcare professional before use. Individual results may vary.

FTC Affiliate Disclosure: This press release contains affiliate links. If a purchase is made through these links, a sales commission may be earned by the publishing partner at no additional cost to the buyer. Disclosure complies with 16 CFR Part 255 regarding endorsements and testimonials in advertising. The existence of this affiliate relationship does not influence the factual content of this release.

Editorial Disclaimer: This news release is provided for informational purposes only. It does not constitute medical advice, diagnosis or treatment planning.

About Memopezil

Memopezil is a daily capsule supplement for adults, distributed by GEX Corp of Lakeland, Florida. Its stated approach is to keep the formulation short and fully disclosed: five active ingredients, each with its milligram amount printed on the panel rather than hidden inside a proprietary blend, so buyers can check any listing against the label. It is sold through its own website.

Each two-capsule serving supplies branched chain amino acids 540 mg, Bacopa monnieri extract 200 mg, Rhodiola rosea extract 100 mg, L-theanine 100 mg and Panax ginseng extract 90 mg. Bottles contain 60 capsules, or 30 servings. The label states the product is made in the USA with globally sourced ingredients and manufactured in an FDA-registered facility. Purchases placed through the company’s checkout carry a 60-day money-back guarantee, under which refunds are available between day 30 and day 60 following a minimum 30-day trial period.

Media Contact

• Contact person: Kevin S., product head, Memopezil

• Company: GEX Corp, distributor of Memopezil

• Email: support@realmemopezil.com

• Telephone: +1 507-448-8190

• Address: GEX Corp, Lakeland, FL 33804, USA

• Website: realmemopezil.com

Citation Verification List

• 1. Bacopa monnieri: Kongkeaw, C., et al. (2014). J Ethnopharmacol, 151(1), 528–535. doi:10.1016/j.jep.2013.11.008 — VERIFIED (PubMed 24252493)

• 2. Rhodiola rosea: Hung, S.K., Perry, R., & Ernst, E. (2011). Phytomedicine, 18(4), 235–244 — VERIFIED (PubMed 21036578)

• 3. L-Theanine: Hidese, S., et al. (2019). Nutrients, 11(10), 2362. doi:10.3390/nu11102362 — VERIFIED (PubMed 31623400)

• 4. Panax ginseng: Geng, J., et al. (2010). Cochrane Database Syst Rev, (12), CD007769. doi:10.1002/14651858.CD007769.pub2 — VERIFIED (PubMed 21154383)

• 5. Branched chain amino acids: Fernstrom, J.D. (2005). J Nutr, 135(6 Suppl), 1539S–1546S — VERIFIED (PubMed 15930466)

• 6. Consumer reporting: U.S. Federal Trade Commission, reportfraud.ftc.gov — VERIFIED (Federal agency)

• 7. Adverse event reporting: U.S. Food and Drug Administration MedWatch, fda.gov/medwatch — VERIFIED (Federal agency)

• 8. Consumer health resources: National Institute on Aging, nia.nih.gov; National Center for Complementary and Integrative Health, nccih.nih.gov — VERIFIED (Federal agency sites)

For more press release distribution and guest post services, visit TS Newswire.